Results 261 to 270 of about 207,050 (299)

Increased Prostate-Specific Membrane Antigen Uptake in Neurofibromatosis

Clinical Nuclear Medicine, 2020
Abstract A 51-year-old man with 30-year neurofibromatosis and 2-month elevated prostate-specific antigen and back pain underwent a 68Ga–prostate-specific membrane antigen (PSMA) PET/CT scan for possible prostate cancer. Prostate-specific membrane antigen PET/CT imaging showed no abnormal uptake of the prostate.
Yingwei, Wang, Cheng, Zeng, Huipan, Liu, Yue, Chen, Wei, Zhang   +4 more
openaire   +2 more sources

Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals

PET Clinics
Novel prostate-specific membrane antigen (PSMA) ligands labeled with α-emitting radionuclides are sparking a growing interest in prostate cancer treatment. These targeted alpha therapies (TATs) have attractive physical properties that deem them effective in progressive metastatic castrate-resistant prostate cancer (mCRPC).
Honest Ndlovu, Kgomotso M.G. Mokoala, Ismaheel Lawal, Louise Emmett, Mike M. Sathekge   +4 more
openaire   +2 more sources

Prostate‐specific membrane antigen expression in melanoma metastases

Journal of Cutaneous Pathology, 2020
AbstractBackgroundProstate‐specific membrane antigen (PSMA) is a prostatic epithelial protein that is used as a radiotracer (68Ga‐PSMA‐11) for prostate cancer staging. PSMA‐PET/CT (positron emission tomography/computed tomography) performed for prostate cancer has been observed to detect melanoma metastases. The aim of this study was to investigate the
Hayden Snow, Stephen Hazell, Nicholas Francis, Kabir Mohammed, Stephanie O'Neill, Emma Davies, David Mansfield, Christina Messiou, Nabil Hujairi, David Nicol, Kevin Harrington, Myles Smith   +11 more
openaire   +3 more sources

68Ga–Prostate-Specific Membrane Antigen–Avid Tubercular Lesions Mimicking Prostate Cancer Metastasis on Simultaneous Prostate-Specific Membrane Antigen PET/MRI

Clinical Nuclear Medicine, 2017
Abstract 68Ga–prostate-specific membrane antigen (PSMA) has gained increasing interest as a target molecule in imaging of prostate cancer because of its selective overexpression in local prostate cancer lesions and metastasis.
Aashim, Ahuja, Sangeeta, Taneja, Kiran, Thorat, Amarnath, Jena   +3 more
openaire   +2 more sources

Radiolabeled prostate-specific membrane antigen small-molecule inhibitors

The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 2017
Prostate cancer (PC) is one of the most common malignancies worldwide. Prostate-specific membrane antigen (PSMA) has been found to be expressed in most PCs and represents an ideal target for diagnostic and therapeutic purposes. Numerous PSMA tracers have been recently developed.
Leon, Will, Ida, Sonni, Klaus, Kopka, Clemens, Kratochwil, Frederik L, Giesel, Uwe, Haberkorn   +5 more
openaire   +2 more sources

Prostate Specific Membrane Antigen Based Imaging

2021
Positron emission tomography-computed tomography (PET-CT) performed with new radiopharmaceuticals has revolutionized the imaging area in prostate cancer (Pca). 68Ga/18F-labeled prostate-specific membrane antigen (PSMA) has been the most promising radiotracer for staging and restaging of Pca.
openaire   +1 more source

Prostate Specific Membrane Antigen-Based Diagnostics

2012
At present, prostate cancer imaging is performed for lesion localization, detection of recurrent and/or metastatic disease, and staging. Despite significant efforts, conventional imaging of prostate cancer does not contribute to patient management as much as imaging performed for other common cancers.
Joseph R. Osborne, Kofi Deh, Alok Azad Anand, Neil H. Bander, Scott T. Tagawa   +4 more
openaire   +1 more source

Incidental Prostate-Specific Membrane Antigen–Avid Vestibular Schwannoma Detected on 68Ga–Prostate-Specific Membrane Antigen PET/CT

Clinical Nuclear Medicine
Abstract A 62-year-old man was referred for a 68Ga–prostate-specific membrane antigen (PSMA) PET/CT scan for newly diagnosed prostate cancer (ISUP grade 5), on the background of left vestibular schwannoma treated with surgical excision 25 years ago.
Jeffrey, Chen, Paul, Bui, Chuong, Bui, Robert, Mansberg   +3 more
openaire   +2 more sources

Prostate‐specific membrane antigen

British Journal of Urology, 1998
B H, Maraj, P, Whelan, A F, Markham
openaire   +2 more sources

Prostate‐specific membrane antigen expressing angiolipoma

ANZ Journal of Surgery, 2020
Xuan Rui Sean Ong, Laurence Galea, Scott Donnellan, Paul Manohar   +3 more
openaire   +2 more sources